Skip to content!

Topic Research and Development

clear
0 filter(s) selected
close
Go to page
remove add
171 results, from 21
  • Diskussionspapiere 1942 / 2021

    R&D Internationalization Strategies of the World’s Top Corporate R&D Investors

    This paper contributes to the debate on the internationalization of the R&D activity of multinational enterprises (MNEs). Specifically, we examine the following research questions: (1) What are the determinants of the MNEs’ R&D internationalization level? (2) What types of internationalization strategies—home-base-augmenting (HBA), home-base-exploiting (HBE), technology-seeking (TS), and/or market-seeking ...

    2021| Heike Belitz, Anna Lejpras
  • Externe referierte Aufsätze

    Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis

    We investigate patterns in common ownership networks between firms that are active in the U.S. pharmaceutical industry for the period 2004–2014. Our main findings are that “brand firms”—that is, firms that have research and development capabilities and launch new drugs—exhibit relatively dense common ownership networks with each other that further increase significantly in density over time, whereas ...

    In: The Antitrust Bulletin 66 (2021), 1, S. 68–99 | Albert Banal-Estañol, Melissa Newham, Jo Seldeslachts
  • Diskussionspapiere 1930 / 2021

    Market Concentration in Europe: Evidence from Antitrust Markets

    An increasing body of empirical evidence is documenting trends toward rising concentration, profits, and markups in many industries around the world since the 1980s. Two major criticisms of these studies is that concentration and market shares are poorly measured at the national industry level while firm level revenues are a poor indicator of product sales. We use a novel database that identifies over ...

    2021| Pauline Affeldt, Tomaso Duso, Klaus Gugler, Joanna Piechucka
  • Brown Bag Seminar Industrial Economics

    Determinants and effects of mergers and acquisitions: Evidence from drug projects in the diabetes market

    This is an online seminar using Webex. You will receive the login data with the invitation to the talk. Abstract:   There is an ongoing debate both in academia and in policy circles about the effects of takeovers of small, young firms by large incumbents in innovative industries. Many argue that such takeovers are anticompetitive and harm innovation by killing off nascent competition....

    10.07.2020| Jan Malek
  • Report

    DG Competition of the European Commission publishes several studies evaluating State aid rules provided by a consortium with the participation of the DIW Berlin

    On 2 June 2020 DG Competition of the European Commission published several support studies on the retrospective evaluation of State aid rules. This “Fitness check” will serve as a basis for future Commission’s decisions about whether to further prolong or update the rules expiring in 2020. The consortium of DIW Berlin, Lear, Sheppard Mullin and UEA Consulting under the leadership ...

    18.06.2020| Tomaso Duso
  • DIW Applied Micro Seminar

    What do we want? And when do we want it? Alternative objectives and their implications for experimental design.

    Summary:  This talk will provide a survey of several papers on the theory and practice of experimental design. I will compare different objectives (estimator precision, outcomes of participants, informing policy choice to maximize average outcomes, and informing policy choice to maximize utilitarian welfare), and their implications for experimental design. I will consider heuristic...

    24.04.2020| Maximilian Kasy, University of Oxford
  • Diskussionspapiere 1918 / 2020

    Common Ownership in the US Pharmaceutical Industry: A Network Analysis

    We investigate patterns in common ownership networks between firms that are active in the US pharmaceutical industry for the period 2004-2014. Our main findings are that “brand firms” — i.e. firms that have R&D capabilities and launch new drugs — exhibit relatively dense common ownership networks with each other that further increase significantly in density over time, whereas the network of “generic ...

    2020| Albert Banal-Estanol, Melissa Newham, Jo Seldeslachts
  • Diskussionspapiere 1887 / 2020

    R&D Spillovers throught RJV Cooperation

    We investigate the dimensions through which R&D spillovers are propagated across firms via cooperation through Research Joint Ventures (RJVs). We build on the framework developed by Bloom et al. (2013) which considers the opposing effects of technology spillovers and product market rivalry, and extend it to account for RJVs. Our main findings are that the adverse effects of product market rivalry are ...

    2020| Albert Banal-Estañol, Tomaso Duso, Jo Seldeslachts, Florian Szücs
  • Externe referierte Aufsätze

    Microfirms and Innovation in the Service Sector

    In: Small Business Economics 55 (2020), 4, S. 997-1018 | David B. Audretsch, Alexander S. Kritikos, Alexander Schiersch
  • Externe Monographien

    Retrospective Evaluation of the Regional Aid Framework: Final Report

    Brussels: European Union, 2020, 288 S. | Tomaso Duso, Joanna Piechucka, Jo Seldeslachts [u.a.]
171 results, from 21
keyboard_arrow_up